Amgen Inc. (AMGN) /

The debt of Amgen Inc. over the past 10 years

Chart Amgen Inc.: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →

At the end of fiscal 2025, the latest fiscal year on file, Amgen Inc. had liquid cash of $9.13B and total debt of $54.6B: net debt of $45.48B. It had more liquid cash than debt at 2 of the 10 year-ends shown. Total debt was highest at the end of fiscal 2023 ($64.61B) and lowest at the end of fiscal 2019 ($29.9B).

Year by year

Fiscal yearLiquid cashTotal debt*Net cash*
2025ended Dec 31, 2025$9.13B$54.6B-$45.48B
2024ended Dec 31, 2024$11.97B$60.1B-$48.13B
2023ended Dec 31, 2023$10.94B$64.61B-$53.67B
2022ended Dec 31, 2022$9.3B*$38.95B-$29.64B
2021ended Dec 31, 2021$8.04B*$33.31B-$25.27B
2020ended Dec 31, 2020$10.65B*$32.99B-$22.34B
2019ended Dec 31, 2019$8.91B*$29.9B-$20.99B
2018ended Dec 31, 2018$29.3B*$33.93B-$4.63B
2017ended Dec 31, 2017$41.68B*$35.34B$6.34B
2016ended Dec 31, 2016$38.09B*$34.6B$3.49B

Fiscal years as Amgen Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.

More on Amgen Inc.

Companies of a similar size

Not investment advice. This page shows what Amgen Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.